These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23793764)

  • 21. Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets.
    Schmid-Alliana A; Schmid-Antomarchi H; Al-Sahlanee R; Lagadec P; Scimeca JC; Verron E
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29300334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate cancer bone metastases promote both osteolytic and osteoblastic activity.
    Keller ET; Brown J
    J Cell Biochem; 2004 Mar; 91(4):718-29. PubMed ID: 14991763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of osteotropism on both sides of the breast cancer-bone interaction.
    Moreau J; Anderson KM; Mauney JR; Kaplan D; Rosenblatt M
    Ann N Y Acad Sci; 2007 Nov; 1117():328-44. PubMed ID: 17584985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
    Sasaki A; Boyce BF; Story B; Wright KR; Chapman M; Boyce R; Mundy GR; Yoneda T
    Cancer Res; 1995 Aug; 55(16):3551-7. PubMed ID: 7627963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular mechanisms and treatment of bone metastasis.
    Clines GA; Guise TA
    Expert Rev Mol Med; 2008 Mar; 10():e7. PubMed ID: 18321396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone metastatic process of breast cancer involves methylation state affecting E-cadherin expression through TAZ and WWOX nuclear effectors.
    Matteucci E; Maroni P; Luzzati A; Perrucchini G; Bendinelli P; Desiderio MA
    Eur J Cancer; 2013 Jan; 49(1):231-44. PubMed ID: 22717556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of Wnts in bone metastases.
    Hall CL; Keller ET
    Cancer Metastasis Rev; 2006 Dec; 25(4):551-8. PubMed ID: 17160558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical imaging of the cellular and molecular events in the multistep process of bone metastasis.
    van der Horst G; van der Pluijm G
    Future Oncol; 2012 Apr; 8(4):415-30. PubMed ID: 22515445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.
    Capulli M; Angelucci A; Driouch K; Garcia T; Clement-Lacroix P; Martella F; Ventura L; Bologna M; Flamini S; Moreschini O; Lidereau R; Ricevuto E; Muraca M; Teti A; Rucci N
    J Bone Miner Res; 2012 Nov; 27(11):2387-98. PubMed ID: 22714395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel model of bone-metastatic prostate cancer in immunocompetent mice.
    Power CA; Pwint H; Chan J; Cho J; Yu Y; Walsh W; Russell PJ
    Prostate; 2009 Nov; 69(15):1613-23. PubMed ID: 19585491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The application advances of bisphosphonates in bone metastasis].
    Liang P
    Zhongguo Gu Shang; 2008 Jun; 21(6):480-2. PubMed ID: 19108448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
    Armstrong AP; Miller RE; Jones JC; Zhang J; Keller ET; Dougall WC
    Prostate; 2008 Jan; 68(1):92-104. PubMed ID: 18008334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Animal model for mammary tumor growth in the bone microenvironment.
    Futakuchi M; Singh RK
    Breast Cancer; 2013 Jul; 20(3):195-203. PubMed ID: 23335063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Models of metastatic prostate cancer: a transgenic perspective.
    Winter SF; Cooper AB; Greenberg NM
    Prostate Cancer Prostatic Dis; 2003; 6(3):204-11. PubMed ID: 12970722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
    Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
    Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of cyclooxygenase-2 (COX-2) inhibition on human prostate cancer induced osteoblastic and osteolytic lesions in bone.
    Gamradt SC; Feeley BT; Liu NQ; Roostaeian J; Lin YQ; Zhu LX; Sharma S; Dubinett SM; Lieberman JR
    Anticancer Res; 2005; 25(1A):107-15. PubMed ID: 15816526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival.
    Cheville JC; Tindall D; Boelter C; Jenkins R; Lohse CM; Pankratz VS; Sebo TJ; Davis B; Blute ML
    Cancer; 2002 Sep; 95(5):1028-36. PubMed ID: 12209687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The molecular biology of pulmonary metastasis.
    Krishnan K; Khanna C; Helman LJ
    Thorac Surg Clin; 2006 May; 16(2):115-24. PubMed ID: 16805200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Animal Models of Bone Metastasis.
    Simmons JK; Hildreth BE; Supsavhad W; Elshafae SM; Hassan BB; Dirksen WP; Toribio RE; Rosol TJ
    Vet Pathol; 2015 Sep; 52(5):827-41. PubMed ID: 26021553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.